NCT02708173View on ClinicalTrials.gov

Safety Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged 3 Years and Older

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

March 31, 2016

Study Completion Date

June 30, 2016

Conditions
Quadrivalent Influenza Virus Vaccine
Interventions
BIOLOGICAL

One dose of Quadrivalent Influenza Virus Vaccine

BIOLOGICAL

One dose of Quadrivalent Influenza Virus Vaccine

Trial Locations (1)

100021

DongBa clinical center, Beijing

All Listed Sponsors
lead

Beijing Chaoyang District Centre for Disease Control and Prevention

OTHER

NCT02708173 - Safety Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged 3 Years and Older | Biotech Hunter | Biotech Hunter